measles (redirected from hemorrhagic measles)

measles or rubeola (rbē`ələ), highly contagious disease of young children, caused by a filterable virus and spread by droplet spray from the nose, mouth, and throat of individuals in the infective stage. This period begins 2 to 4 days before the appearance of the rash and lasts from 2 to 5 days thereafter. The first symptoms of measles, after an incubation period of 7 to 14 days, are fever, nasal discharge, and redness of the eyes. Characteristic white spots appear in the mouth, followed by a rash on the face that spreads to the rest of the body. The symptoms disappear in 4 to 7 days. One attack of measles confers lifelong immunity. However, it renders the patient susceptible to other more serious infections such as bronchial pneumonia and encephalitis. The measles virus has also been associated with subacute sclerosing panencephalitis (SSPE), which causes chronic brain disease in children and adolescents. After the attack of measles, it can cause intellectual deterioration, convulsive seizures, and motor abnormalities and is usually fatal. Common measles in pregnant women can be a threat to the unborn child, and vaccination of women well before pregnancy is recommended (see also rubella, or German measles).

Immunization by injection of live measles-virus vaccine, first marketed in 1963, has proven effective. Given at first with gamma globulin, the vaccine was further developed by 1965 so that one shot alone gives long-term, probably lifetime, immunity; a nationwide program was established in the United States for the vaccination of all children over the age of nine months.

---

measles

 or rubeola

Highly contagious viral childhood disease. It initially resembles a severe cold with red eyes and fever; a blotchy rash and higher fever later develop. After recovery, patients have lifelong immunity. Adult patients tend to have more severe cases. Antibiotics now prevent death from secondary infections. Measles itself, for which there is no drug, requires only bed rest, eye protection, and steam for bronchial irritation. A vaccine developed in the 1960s proved not to give permanent immunity and is too heat-sensitive for use in tropical areas. The worldwide incidence of measles continues to rise. Research is currently directed toward development of a more stable vaccine. See also rubella.

---

measles

1. a highly contagious viral disease common in children, characterized by fever, profuse nasal discharge of mucus, conjunctivitis, and a rash of small red spots spreading from the forehead down to the limbs

2. a disease of cattle, sheep, and pigs, caused by infestation with tapeworm larvae

---

Measles

An acute, highly infectious viral disease with cough, fever, and maculopapular rash. It is of worldwide endemicity.

The virus enters the body via the respiratory system, multiplies there, and circulates in the blood. Cough, sneezing, conjunctivitis, photophobia, and fever occur, with Koplik's spots (small red spots containing a bluish-white speck in the center) in the mouth.

A rash appears after 14 days' incubation and persists 5–10 days. Serious complications may occur in 1 out of 15 persons; these are mostly respiratory (bronchitis, pneumonia), but neurological complications are also found. Encephalomyelitis occurs rarely. Permanent disabilities may ensue for a significant number of persons. Measles is one of the leading causes of death among children in the world, particularly in the developing countries.

In unvaccinated populations, immunizing infections occur in early childhood during epidemics which recur after 2–3 years' accumulation of susceptible children. Transmission is by coughing or sneezing. Measles is infectious from the onset of symptoms until a few days after the rash has appeared. Second attacks of measles are very rare. Treatment is symptomatic.

Killed virus vaccine should not be used, as certain vaccinees become sensitized and develop local reactions when revaccinated with live attenuated virus, or develop a severe illness upon contracting natural measles. Live attenuated virus vaccine effectively prevents measles; vaccine-induced antibodies persist for years. See Biologicals, Hypersensitivity, Skin test